![Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline | World Pharma Today Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline | World Pharma Today](https://www.worldpharmatoday.com/wp-content/uploads/2020/07/catalant_edidas.jpg)
Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline | World Pharma Today
![CRISPR Gene Editing Market: Current Analysis and Forecast (2022-2028) | Analysis, Growth marketing, Marketing trends CRISPR Gene Editing Market: Current Analysis and Forecast (2022-2028) | Analysis, Growth marketing, Marketing trends](https://i.pinimg.com/736x/03/9e/6a/039e6aa210f44f7f773c74b6fe2110fa.jpg)
CRISPR Gene Editing Market: Current Analysis and Forecast (2022-2028) | Analysis, Growth marketing, Marketing trends
![Over $1bn raised in venture capital funding for gene editing in 2021 - Pharma Technology Focus | Issue 116 | March 2022 Over $1bn raised in venture capital funding for gene editing in 2021 - Pharma Technology Focus | Issue 116 | March 2022](https://pharma.nridigital.com/pharma/pharma_mar22/venture-capital-gene-editing-funding/1220135/cda.960_0_1.png)
Over $1bn raised in venture capital funding for gene editing in 2021 - Pharma Technology Focus | Issue 116 | March 2022
![Paras Sharma on X: "Gene Therapy landscape by delivery method & stage (only pub companies) Source: Cowen https://t.co/vxKNS4MOWX" / X Paras Sharma on X: "Gene Therapy landscape by delivery method & stage (only pub companies) Source: Cowen https://t.co/vxKNS4MOWX" / X](https://pbs.twimg.com/media/FM0J7IhWYAExFhY.jpg:large)
Paras Sharma on X: "Gene Therapy landscape by delivery method & stage (only pub companies) Source: Cowen https://t.co/vxKNS4MOWX" / X
Syneos Health | Gene Editing Your Cell Therapy: Key Considerations for Biopharma Companies and Investors
![Integrated DNA Technologies and Aldevron® Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers | Business Wire Integrated DNA Technologies and Aldevron® Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers | Business Wire](https://mms.businesswire.com/media/20230918880664/en/1891850/5/IDT_Aldevron_Partnership_Distribution_Announcement_-1200_x675.jpg)
Integrated DNA Technologies and Aldevron® Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers | Business Wire
![Pairwise Grants U.K. Company Access to its Gene Editing Technology | North Carolina Biotechnology Center Pairwise Grants U.K. Company Access to its Gene Editing Technology | North Carolina Biotechnology Center](https://www.ncbiotech.org/sites/default/files/inline-images/Pairwise_Logo_600px_1.jpg)
Pairwise Grants U.K. Company Access to its Gene Editing Technology | North Carolina Biotechnology Center
![Paras Sharma on X: "Gene Editing landscape by delivery method & stage (only pub companies) Source: Cowen https://t.co/Pl5J1Db3Nv" / X Paras Sharma on X: "Gene Editing landscape by delivery method & stage (only pub companies) Source: Cowen https://t.co/Pl5J1Db3Nv" / X](https://pbs.twimg.com/media/FM4x_paXsAMDNRN.jpg:large)
Paras Sharma on X: "Gene Editing landscape by delivery method & stage (only pub companies) Source: Cowen https://t.co/Pl5J1Db3Nv" / X
![Gene Editing Market Revenue to Touch $7.4 Billion by 2031 | Major Companies, Strategies and New Trends - PharmiWeb.com Gene Editing Market Revenue to Touch $7.4 Billion by 2031 | Major Companies, Strategies and New Trends - PharmiWeb.com](https://www.alliedmarketresearch.com/assets/sampleimages/gene-editing-market-1656596454.png)
Gene Editing Market Revenue to Touch $7.4 Billion by 2031 | Major Companies, Strategies and New Trends - PharmiWeb.com
![Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics Institute | Gene Therapy Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics Institute | Gene Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41434-023-00392-3/MediaObjects/41434_2023_392_Fig1_HTML.png)